Efficacy of allogeneic haematopoietic stem cell transplantation in acute myeloid leukemia with myelodysplasia-related genetics.

doi:10.1080/10428194.2026.2687634

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Efficacy of allogeneic haematopoietic stem cell transplantation in acute myeloid leukemia with myelodysplasia-related genetics.

Leukemia & lymphoma - 1 Aug 2026

Rui Jingwen, Gao Rui, Shen Yifan, Wu Depei, Xu Yang, Zhou Biqi

Abstract excerpt

Acute myeloid leukemia with myelodysplasia-related (AML-MR) gene mutations is associated with high rates of relapse and mortality and has limited prognostic benefits. To assess the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in AML-MR patients, 196 AML-MR patients who underwent allo-HSCT at our center were retrospectively analyzed. Patients who received hypomethylating agents (HMAs)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Hematopoietic Stem Cell Transplantation
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Myelodysplastic Syndromes

Share to Prognosis

Share to Transplantation, Homologous

Share to Treatment Outcome

Share to Young Adult

Source

Open in PubMed

Identifiers

PMID: 42315846
DOI: 10.1080/10428194.2026.2687634

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.